$0.00

(%)
Live
Previous Close

$

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$878.2 million USD

Day Vol.

Previous Day Vol.

Currency

USD

Primary Exchange

Nasdaq

OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical ...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

OPKO Health (OPK) expects to re-establish profitability in its clinical laboratory business via its latest efforts to streamline its laboratory services business.

Related tickers: LH, DVA, CAH, OPK.

Read Full Article

Across the recent three months, 4 analysts have shared their insights on OPKO Health (NASDAQ:OPK), expressing a variety of opinions spanning from bullish to bearish. The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 3 0 0 0 Last 30D 0 2 0 0 0 1M Ago 0 0 0 0 0 2M Ago 1 1 0 0 0 3M Ago 0 0 0 0 0 Insights from analysts' 12-month price targets are revealed, presenting an average target of $2.75, a high estimate of $5.00, and a low estimate of $1.50. This upward trend is evident, with the current average reflecting a 57.14% increase from the previous average price target of $1.75. Deciphering Analyst Ratings: An In-Depth Analysis The perception of OPKO Health by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Michael Petusky Barrington Research Maintains Outperform $1.50 $1.50 Edward Tenthoff Piper Sandler Maintains Overweight $5.00 - Yi Chen HC Wainwright & Co. Maintains Buy $3.00 - Michael Petusky Barrington Research Lowers Outperform $1.50 $2.00 Key Insights: Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to OPKO Health. This ...Full story available on Benzinga.com

Related tickers: OPK.

Read Full Article
Trending Tickers
DATS

XNAS

$1.24
(%)
LASE

XNAS

$2.10
(%)
NYCB

XNYS

$2.97
(%)
PACW

XNAS

$7.54
(%)
MLGO

XNAS

$0.00
(%)